| Name | Nicaraven |
| Description | Nicaraven, a hydroxyl radical scavenger, has neuroprotective and antivasospastic effects. |
| In vitro | Nicaraven causes a dose-dependent, slight inhibition of poly (ADP-ribose) synthetase activation, possibly due to a direct inhibitory effect on the catalytic activity of poly (ADP-ribose) synthetase in RAW murine macrophages stimulated with peroxynitrite. Nicaraven partially protects against the peroxynitrite-induced suppression of mitochondrial respiration in RAW macrophages and causes a slight, dose-dependent inhibition of nitrite production in RAW macrophages stimulated with bacterial lipopolysaccharide. [1] Nicaraven (0.35 mM) significantly inhibits the maximum aggregation rate induced by adenosine diphosphate (ADP) in the healthy volunteer platelets. Nicaraven (1.75 mM) significantly reduces the maximum aggregation rate induced by collagen in platelets. Nicaraven induces dose-dependent inhibition of platelet aggregation in both healthy volunteers and patients with cerebral thrombosis. [2] |
| In vivo | Nicaraven inhibits lipid peroxidation in the liver of beagle dogs, improves hepatic and systemic hemodynamics and energy metabolism, and suppresses liver enzyme release, endothelin-1 elevation in hepatic venous blood, histologic damage, and neutrophil infiltration into the liver [3]. Nicaraven (20 mg/kg) slightly reduces infarction volume in male Sprague-Dawley rats subjected to transient focal ischemia, while a dose of 60 mg/kg significantly reduces infarction volume by 18.6% and 20.9% in pre- and posttreatment groups, respectively [4]. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : 53 mg/mL (186.42 mM), Sonication is recommended.
H2O : 52 mg/mL (182.9 mM), Sonication is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (7.03 mM), Sonication is recommended.
DMSO : 45 mg/mL (158.28 mM), Sonication is recommended.
|
| Keywords | Nicaraven | Inhibitor | inhibit |
| Inhibitors Related | Ethoxyquin | Kaolin | Allopurinol | L-Ascorbic acid | Ethyl linoleate | Magnesium acetate tetrahydrate | Inosine | L-Cystine | Copper Sulfate Pentahydrate | Dimethyl itaconate | L-Ascorbic acid sodium salt | Dimethyl phthalate |
| Related Compound Libraries | Ferroptosis Compound Library | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | ReFRAME Related Library | Neuroprotective Compound Library | NO PAINS Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Human Metabolite Library |
United States
